We all know that a primary driver of the high cost of drug development is clinical trials. The process is not only costly, but lengthy and difficult. And even once you complete the four phases and submit your data to the FDA, there is no guarantee the drug will be approved. All this might make you wonder: Could the drug development process be made easier if we had a clinical researcher at the helm of the FDA? You may not need to wonder much longer.
↧